Oracle (ORCL) shares have plunged roughly 66% from their all-time high, hitting a fresh 52-week low of $114.75 on Friday. Yet Wall Street analysts covering the stock maintain an average price target around $248 — more than double the current price near $117. The extraordinary gap reflects a single unresolved question: can Oracle’s enormous backlog of artificial intelligence contracts convert into cash before the massive build-out costs swallow the company?
The sell-off is a direct response to spending. Capital expenditures reached $55.7 billion in fiscal 2026, overwhelmingly directed at cloud infrastructure data centers. Operating cash flow surged 54% to a record $32 billion, but the build-out consumed every dollar of it, leaving full-year free cash flow at negative $23.7 billion. The bill is arriving in other forms as well. S&P Global Ratings downgraded Oracle’s credit rating to BBB- earlier this month, just one notch above junk, explicitly citing the cost of the expansion. Oracle also said it expects to raise $40 billion through debt and equity financing this fiscal year, including a $20 billion share sale that will dilute existing shareholders.
When a company burns more than $20 billion of cash annually, the market stops paying a premium for earnings and starts scrutinizing the balance sheet. A forward price-to-earnings multiple below 15 times no longer signals doubts about growth durability alone — it is pricing in the risk of a deteriorating financial foundation.
The other side of the argument rests on a business that keeps accelerating. Oracle’s total revenue rose 17% in fiscal 2026 to $67.4 billion, with growth picking up each quarter. Fourth-quarter revenue climbed 21% year over year. Even more striking, the cloud infrastructure unit — the business that rents computing power to AI customers — grew 77% for the full year and surged 93% in the fourth quarter alone, reaching $5.8 billion. GAAP earnings per share came in at $5.83, up 34%, and while one-time gains flattered that number, adjusted earnings still rose 13%.
More significant than past results is the towering contract backlog. Remaining performance obligations finished fiscal 2026 at $638 billion after swelling by $85 billion in just the final quarter. Within that mountain, AI deals where customers either prepay or supply their own GPUs now total roughly $75 billion, effectively shifting part of the spending burden onto clients. Management is guiding for roughly $90 billion in revenue this fiscal year, growth of about 34%. Around 12% of the current backlog is expected to convert into revenue this fiscal year, with another 34% to be realized over the following 13 to 36 months. If the bulk of these signed contracts converts on schedule, the arithmetic behind a $248 target is not difficult to follow.
The market is pricing signed contracts as if they were speculative stories, while analysts are extrapolating a backlog whose single largest customer is itself an unprofitable AI company. Stuck between the two narratives is the reality that Oracle is pivoting from a high-margin software business toward capital-intensive AI infrastructure. Management has already warned that capital expenditures could reach as high as $70 billion in fiscal 2027 and that margins will take “a step down” in the near term.
At less than 15 times guided earnings, the stock looks cheap compared to the tech sector’s average multiple of 34. But the critical variables are not relative valuation metrics — they are whether free cash flow finds a floor and whether the contract backlog converts into real cash on time. The prevailing view is that until several quarters deliver clear evidence on both fronts, the deep divide between the stock price and analyst targets is unlikely to close. For investors tempted by the prospect of a double, the heavy punishment the shares have absorbed has its reasons, and keeping positions small and cautious may be the most rational choice right now.
